Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/29/2025

Modafinil for Sleep Disorders: Recommended Use and Dosing

Introduction to Modafinil

  • The American Academy of Sleep Medicine recommends modafinil as the first-line treatment for excessive daytime sleepiness in narcolepsy, with a standard dose of 200 mg taken once daily in the morning, which can be increased to 400 mg daily if needed 1

FDA-Approved Indications

  • Modafinil is FDA-approved for narcolepsy (excessive daytime sleepiness) 2

Standard Dosing Protocols

  • The American Geriatrics Society recommends a starting dose of 100 mg once upon awakening in the morning for elderly patients, with titration at weekly intervals as necessary, and a typical maintenance range of 200-400 mg per day 2

Clinical Efficacy Evidence

  • The American Academy of Sleep Medicine provides a strong recommendation for modafinil in narcolepsy based on moderate-quality evidence from 9 randomized controlled trials and 4 observational studies, with clinically significant improvements in excessive daytime sleepiness, disease severity, and quality of life 1
  • Modafinil does not suppress cataplexy, requiring separate treatment with antidepressants or sodium oxybate 2
  • Modafinil maintains nocturnal sleep architecture without disrupting nighttime sleep 2

Important Safety Considerations

  • Common adverse effects of modafinil include headache, nausea, nervousness, insomnia, diarrhea, dry mouth, back pain, anxiety, dizziness, and dyspepsia 1, 2, 4
  • The American Academy of Sleep Medicine recommends monitoring blood pressure, heart rate, and cardiac rhythm when initiating or adjusting modafinil doses, with a watch for hypertension, palpitations, and arrhythmias 2

Pharmacokinetic Properties

  • Modafinil has a half-life of approximately 15 hours, with a time to steady state of 2-4 days of dosing, and a peak plasma concentration of 2-3 hours after oral administration 4

Monitoring During Treatment

  • The American Geriatrics Society recommends frequent follow-up when starting or adjusting modafinil doses, with assessment for excessive stimulatory effects, nocturnal sleep disturbances, and behavioral changes, including psychosis 2

REFERENCES

1

treatment of central disorders of hypersomnolence: an american academy of sleep medicine clinical practice guideline. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021

3

psychostimulants for cancer-related fatigue. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010